MedTrace Logo

Personal Health Train for Radiation Oncology in India and The Netherlands

NCT04655469 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2025-08-22

No results posted yet for this study

Summary

The primary and general objective of this protocol as the current standard of care is to improve the quality of radiotherapy for HNC patients. This will ultimately be achieved by optimizing locoregional tumour control and overall survival and by reducing radiation-induced side effects.

It will also allow the assessment of the effects of newly introduced radiation technology (e.g. proton therapy) for this particular group of patients.

The clinical introduction of this standard follow-up program (SFP) will allow for a systematic and broad scale quality improvement cycle for HNC patients treated with radiotherapy.

Conditions

  • Head and Neck Carcinoma

Sponsors & Collaborators

  • Maastricht Radiation Oncology

    lead OTHER

Principal Investigators

  • Andre Dekker, Prof.Dr.Ir. · Department: GROW School for Oncology and Developmental Biology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-10
Primary Completion
2024-05-15
Completion
2025-12-31

Countries

  • India
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04655469 on ClinicalTrials.gov